The Experts in FDA and USDA Regulatory Matters
EAS Consulting Group is a leading provider of regulatory compliance solutions to industries regulated by FDA, USDA, and supporting agencies. Our team of consultants provide expert guidance for all of your regulatory requirements.
Food
Learn More
Dietary Supplements
Learn More
Pharmaceuticals
Learn More
Medical Devices
Learn More
Tobacco
Learn More
Cosmetics
Learn More
Veterinary
Learn More
Cannabis
Learn More
Our Services: Consulting • Submissions • Auditing • Training • Legal Support
Learn With Us
Seminars
Dietary Supplement Testing and Specifications Seminar
Presented by Shelly BlackwellOctober 12, 2026 | 1:00 PM – 5:00 PM ETSpecifications and testing remain among the most frequently cited deficiencies during FDA inspections of dietary supplement manufacturers. While the requirements of 21 CFR Part 111 have been in place...
Webinars
Import Seafood HACCP: Understanding FDA Requirements for U.S. Seafood Importers
Importing seafood into the United States carries specific responsibilities under FDA’s Seafood HACCP regulations. Firms importing fish and fishery products must comply with 21 CFR 123.12 and establish appropriate verification procedures to demonstrate seafood import compliance.
On Demand Webinars
Animal Food GRAS: Unpacking the Essentials
This webinar explores the history and legal basis of GRAS, compares GRAS to alternative regulatory pathways, and reviews FDA notification and self-determined GRAS approaches. The presentation also discusses the role of qualified experts in establishing GRAS conclusions, species-specific safety considerations, and regulatory challenges associated with novel animal food ingredients.
Latest News
Dietary Supplement Testing and Specifications Seminar
Presented by Shelly BlackwellOctober 12, 2026 | 1:00 PM – 5:00 PM ETSpecifications and testing remain among the most frequently cited deficiencies during FDA inspections of dietary supplement...
FDA Releases Agenda and Opens Public Docket for Listeria monocytogenes Prevention Meeting
FDA has released the agenda and opened a 90-day public docket for its August 2026 Public Meeting on Listeria monocytogenes Prevention, covering ready-to-eat foods, retail food safety, and emerging prevention strategies.
FDA’s Proposed GRAS Rule Clears White House Review
OMB review is one of the final procedural steps before publication of a proposed federal regulation. As FDA moves forward with its proposed GRAS rule, industry stakeholders should carefully review the proposal once released and evaluate any potential implications for their regulatory and product development activities.
Get the Newsletter
Subscribe to EASeNews and join the nearly 20,000 who receive the monthly EASeNews regulatory newsletter.
Need Regulatory Support?
Start the Conversation Today